Hint mode is switched on Switch off

Cardiff Oncology, ordinary share
CRDF, US14147L1089

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Cardiff Oncology, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Cardiff Oncology Inc operates as a biotech company. The Company develops therapies and treatments for solid tumor and hematologic cancers. Cardiff Oncology serves customers in the States of California.
  • Issuer
  • Full borrower / issuer name
    Cardiff Oncology Inc (formerly Trovagene Inc)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRDF
  • Placement
    30.09.2020
  • Lock up period
    180
  • Number of papers
    6,500,000
  • Volume of raised funds
    87.75 mln USD
  • Placement share
    21.54%
  • Final placement price
    13.5 USD
  • Price change since placement date
    -92.87%
  • By capitalization
    407.38 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRDF
  • Placement
    11.12.2024
  • Lock up period
    180
  • Number of papers
    15,384,619
  • Volume of raised funds
    40 mln USD
  • Placement share
    23.13%
  • Final placement price
    2.6 USD
  • Price change since placement date
    -62.96%
  • By capitalization
    172.96 mln USD

Related Stock indices

Registration is required to get access.